Compare TXG & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXG | TWST |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | 2019 | 2018 |
| Metric | TXG | TWST |
|---|---|---|
| Price | $21.98 | $48.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 8 |
| Target Price | $16.82 | ★ $48.75 |
| AVG Volume (30 Days) | ★ 2.6M | 1.5M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 76.97 | 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | $245,893,000.00 | ★ $376,572,000.00 |
| Revenue This Year | N/A | $18.89 |
| Revenue Next Year | $7.32 | $15.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 68.06 | 20.32 |
| 52 Week Low | $6.78 | $23.30 |
| 52 Week High | $23.56 | $57.88 |
| Indicator | TXG | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 64.85 | 55.47 |
| Support Level | $11.62 | $25.67 |
| Resistance Level | $23.56 | $57.88 |
| Average True Range (ATR) | 1.29 | 3.01 |
| MACD | 0.20 | -0.56 |
| Stochastic Oscillator | 99.89 | 22.97 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.